Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019
Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015
Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016
Idiopathic pulmonary fibrosis mortality in the United States: is there any evidence of occupational risk? Source: Eur Respir J 2005; 26: Suppl. 49, 702s Year: 2005
Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study Source: Eur Respir J 2014; 43: 801-807 Year: 2014
Tobacco smoking and risk for idiopathic pulmonary fibrosis: a prospective cohort study in UK Biobank Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017
Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada Source: Eur Respir J 2016; 48: 187-195 Year: 2016
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model Source: Eur Respir J 2016; 48: 780-786 Year: 2016
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020 Year: 2021
Trends in COPD mortality – Tales from the Swedish mortality register Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003
Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD. Source: International Congress 2017 – Markers of COPD progression Year: 2017
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
International trends in COPD mortality, 1995–2017 Source: Eur Respir J, 54 (6) 1901791; 10.1183/13993003.01791-2019 Year: 2019
Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study Source: Eur Respir J 2016; 47: 186-193 Year: 2016
Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014